BUY Eris Lifesciences Limited — Prabhudas Lilladher
byPrabhudas LilladherHorizon: NA (inferred 1 year)14 Feb 2024via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·22 May · 2mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Eris Lifesciences
- BUY — Pawan Maheshwari8 Sept 2026 · ~2 weeks · target ₹1,360 · Target hit
- BUY — Sandeep Jain, Tradeswift7 Sept 2026 · ~2 weeks · target ₹1,430 · Expired
- BUY — Elara Capital28 Aug 2026 · ~1 year · target ₹1,471 · Active
- BUY — HDFC Securities29 Jul 2026 · ~1 year · target ₹1,730 · Active
- BUY — Sandeep Jain, Tradeswift16 Jul 2026 · ~1 year · target ₹1,650 · Active
More from Prabhudas Lilladher
- BUY Cummins India5 Nov 2026 · ~1 year · target ₹5,334 · Active
- BUY Lupin5 Nov 2026 · ~1 year · target ₹2,250 · Active
- BUY Physicswallah5 Nov 2026 · ~1 year · target ₹140 · Target hit
- BUY Harsha Engineers International5 Nov 2026 · ~1 year · target ₹520 · Active
- BUY Kansai Nerolac Paints5 Nov 2026 · ~1 year · target ₹235 · Active

